MBTP started in 2017 with an initial NIH T32 grant award. It was continued in 2022 with a second award. There have been 31 trainees (both NIH-funded and matched positions) between 2017-2024. This has resulted in 8 Ph.D.'s and 2 M.S.'s (18 students are still in graduate training).
Our trainees have gone on to a variety of positions in academia, biotechnology, and the pharmaceutical industry. Three did academic or government (NIH) postdoctoral training as their first position. They work in a variety of places, including Curia, CAS, Celerion, Moderna, and Procter & Gamble.